Minnesota Legislature
HF 4
Status in the House for the 91st Legislature (2019 - 2020)
Revisor number: 19-1678
Description
Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; civil penalties imposed; and money appropriated.
Authors
Actions
House
| 01/10/2019 |
Introduction and first reading, referred to Health and Human Services Policy
|
| 01/14/2019 |
Author added Mariani
pg.
50
|
| 02/07/2019 | |
| 02/21/2019 |
Committee report, to adopt as amended and re-refer to Judiciary Finance and Civil Law Division
pg.
416a
|
| 03/04/2019 |
Committee report, to adopt and re-refer to Ways and Means
pg.
702
|
| 03/04/2019 |
Referred by Chair to Health and Human Services Finance Division
|
| 04/03/2019 |
Motion to recall and re-refer, motion did not prevail State Government Finance Division
pg.
1839
|
| 02/27/2020 |
Division action, to adopt as amended and return to Ways and Means
|
| 03/11/2020 |
Committee report, without further rec to amend, re-refer to State Government Finance Division
pg.
6936a
|
| 03/26/2020 |
Committee report, without further rec to amend, re-refer to Ways and Means
pg.
7101a
|